This blog is all about current FDA approved drugs to treat the hepatitis C virus (HCV) with a focus on treating HCV according to genotype, using information extracted from peer-reviewed journals, liver meetings/conferences, and interactive learning activities.
Risk Of Developing Liver Cancer After HCV Treatment
▼
Tuesday, June 24, 2014
What Impact Will Hepatitis C Drugs Have on Medical Costs?
A new estimate suggests that, for private insurers, the impact of new
hepatitis C treatments – including Sovaldi and any forthcoming
medications – on medical costs will eventually decline, as will the
impact on the growth in spending on overall health care. The notion is
largely based on the current pricing for Sovaldi, which assumes
forthcoming drugs would be similarly priced.
Two factors will be at work, according to PricewaterhouseCoopers
Health Research Institute. Besides lowering the overall cost of treating
hepatitis C sufferers, the market research firm maintains that the
actual number of patients will gradually decline over the next decade as
more patients are treated, including those whose physicians are waiting
for better medications to become available.
What Impact Will Hepatitis C Drugs Have on Medical Costs?
No comments:
Post a Comment